Background. The European Defence Agency was established on 12 July 2004, and is governed by Council Decision (CFSP) 2015/1835 defining the statute, seat and operational rules of the European Defence Agency. The Agency has its headquarters in Brussels. The main task of EDA is to support the Council and the Member States in their effort to improve the Union's defence capabilities in the field of crisis management and to sustain the Common Security and Defence Policy (CSDP) as it currently stands and as it develops in the future. The Agency is structured into four directorates. The Corporate Services Directorate (CSD) and three operational directorates: Industry, Synergies and Enablers (ISE); Capability, Armament & Planning (CAP); Research, Technology and Innovation (RTI).
Background. TEAMLEADER fornisce uno strumento di gestione operativa, sotto forma di applicazione web e mobile, che garantisce ai propri Clienti una gestione aziendale più efficiente. Sono possibili integrazioni con tool online di terze parti tramite Teamleader marketplace.
Background. To guarantee more test capability on high gradient structure testing at 12 GHz, the installation of a new high repetition rate RF source in the TEX laboratory is required. Moreover, the test of this source (modulator and klystron) with higher repetition rate with respect to the actual source is of great interest in the framework of the EUPRAXIA@SPARC_LAB project and for the entire X-band users community. The chosen frequency of 12 GHz is also compatible to other studies within the member states notably at CERN, Trieste, and PSI who have chosen this “European” X- band frequency. Moreover, to upgrade the TEX testing capabilities also to other frequencies of interest and expand the possible users of the LATINO project, the installation of a C-band (6GHz) high repetition rate RF source is requested. The C-band frequency is very interesting in the context of accelerators for medical applications and the development of innovative and more compact injectors for Linac. INFN thus strongly supports the development and production of these Sources through collaboration with industries.
Background. The Union Civil Protection Mechanism ("Mechanism") was first established by Council Decision No. 2001/792/EC Euratom1. Council Decision 2007/779/EC, Euratom of 8 November 2007 established a recast of this Mechanism2 in which currently thirty states - the EU28 and two EEA countries (Norway and Iceland) participate (together "participating states"). The Decision of the European Parliament and of the Council No 1313/2013/EU3 on a Union Civil Protection Mechanism in December 2013 further developed the Mechanism into a comprehensive framework for European cooperation in disaster prevention, preparedness and response. The overall objective of the Mechanism is to strengthen the cooperation among Member States in the field of civil protection and between the Union and the Member States in order to facilitate coordination to improve the effectiveness of system for preventing, preparing for and responding to natural and man-made disasters. In accordance with the principle of subsidiarity, the Mechanism activates support on request of a Member State overwhelmed by a disaster or any affected country in the world. By pooling the civil protection capabilities of the participating states, the Mechanism can ensure better protection primarily of people, but also of the natural and cultural environment and of property. The Mechanism consists of a series of elements facilitating adequate prevention, preparedness and effective response actions at EU level. The elements most relevant for this contract are the following: Member States and the Commission will work more closely together in the field of disaster prevention, including for the establishment of national risk assessments, risk management planning, and assessments of their risk management capability. The outcomes of these assessments will be considered for the setting of priorities in the future strategic exercise framework. The Emergency Response Coordination Centre (ERCC) is the operational heart of the Mechanism. It is operated by DG ECHO4 and is operational 24 hours a day/7 days a week. The role of the ERCC is to facilitate and support the mobilisation and coordination of Member States' civil protection assistance during emergencies. It provides countries with access to a platform of civil protection means available amongst all the participating states. Any country inside or outside the European Union affected by a major disaster can make a request for assistance through the ERCC. Besides acting as a communication ...
Background. EMSO XXXX was set up to establish, coordinate, facilitate and optimize the use of pan-European Regional Facilities and sea operation resources in order to ensure maximum benefit to the ocean observation community. It is devoted to deep-sea processes and water column investigation. EMSO XXXX is a distributed research infrastructure, composed of the Central Hub together with all Regional Facilities contributing to EMSO XXXX by its Members, for undertaking the EMSO Programme.
Background. 1.1 Swansea PSB Governance sets out the importance of the wider Partnership Forum and its diverse, broad membership which meets every six months.
1.2 Over 100 community and groups voluntary groups, public services, businesses and citizens met in October 2019. Due to the pandemic, the Forum did not meet as planned in Spring 2020 and has not been able to meet since, due to pressures on the partners and ongoing response to Covid.
Background. The CTRS in Wales is set by regulations made under Schedule 1B of the Local Government Finance Act 1992 (as inserted by the Local Government Finance Act 2012). On 26th November 2013, the National Assembly for Wales (NAfW) approved two sets of regulations:
Background. The Parties (and some others not party to this Agreement) have entered into the FAIRVASC Consortium Agreement (CA) with an effective date of 1 June 2020.
Background. KYMRIAH è un farmaco ATMP (prodotto medicinale per terapia avanzata) prodotto dai linfociti T del paziente, raccolti mediante aferesi. Le proprietà particolari del Prodotto richiedono procedure speciali. A causa della conservazione particolare e dei requisiti logistici (temperatura inferiore a 120 C), il Prodotto dal centro di stoccaggio europeo (Boenen) sarà consegnato direttamente all’Istituzione, in base alla Licenza e Distribuzione di Novartis Farma AG. Ogni lotto è certificato in conformità ai requisiti GMP europei sotto la responsabilità della Persona Qualificata di Novartis prima della Consegna. Ogni lotto è specifico per il paziente.
Background. 1.1 The working group have been given a brief by the Scrutiny Programme Committee for one off working group to raise issues and ask questions about car park charges and provision across Swansea including information on service performance and plans for improvement.